Money in Bulgaria
Bulgaria - MoneyThe economy likely lost further steam in the fourth quarter, again weighed on by softening consumer spending. Weaker retail sales suggest private consumption moderated again in the quarter, in spite of an extremely tight labor market and improving consumer confidence. The picture is somewhat more mixed, however, for investment activity: While business sentiment weakened in Q4, industrial production recovered some lost ground in October-November and credit continued to expand robustly throughout the quarter. On the political front, the government survived a no-confidence vote over water shortages at the end of January. Meanwhile, the Central Bank stated the country is close to joining the pre-euro exchange-rate mechanism (ERM-II). The government plans to join by end-April, and recently received the backing of IMF Managing Director Kristalina Georgieva.
Bulgaria - Money Data
|Money (annual variation in %)||1.2||8.8||7.6||7.7||8.9|
5 years of economic forecasts for more than 30 economic indicators.
Bulgaria Money Chart
Source: Bulgarian National Bank and FocusEconomics calculations.
|Bond Yield||0.40||0.0 %||Dec 31|
Get a sample report showing our regional, country and commodities data and analysis.
Request a Trial
Start working with the reports used by the world’s major financial institutions, multinational enterprises & government agencies now. Click on the button below to get started.
February 14, 2020
Consumer prices increased 0.9% from the previous month in January, following December’s 0.7% rise.
February 14, 2020
The economy grew 3.5% year-on-year in the fourth quarter, slightly down from the third quarter’s 3.7% outturn but beating market expectations, according to a preliminary release by the Statistical Institute on 14 February.
February 10, 2020
Industrial production fell 1.5% year-on-year in December, after dropping 0.2% in November.
January 15, 2020
Consumer prices increased 0.7% from the previous month in December, following November’s 0.5% rise.
January 10, 2020
Industrial production decreased 0.4% year-on-year in November, after increasing 1.8% in October.